Save 10% off on your first order with coupon code: PANDA10
Pandameds.Com Editorial Team
The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.
Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.
Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers
Recent Blog Post
Zepbound Side Effects: Nausea, GI Symptoms & Muscle Pain Timeline Guide
Zepbound side effects impact approximately 82% of users during the first month of treatment, with nausea (up to 29%), diarrhea (up to 23%), constipation (up to 17%), and vomiting (up to 13%) being the most frequently reported according to FDA prescribing information. These gastrointestinal symptoms typically peak during weeks 4-8 when patients are titrating to [...]
Mounjaro Nausea: 12-24% Rate Peaks Week 4 – 90% Resolve Management Guide
Mounjaro (tirzepatide) is an FDA-approved medication that helps manage blood glucose levels in adults with Type 2 diabetes and is also highly effective for weight loss. While this weight loss injection has shown remarkable results in clinical trials, helping people lose weight significantly, nausea from Mounjaro remains the most common side effect that patients experience [...]
Mounjaro Face: Facial Fat Loss from Rapid Weight Loss – Prevention Guide
Mounjaro face describes the gaunt, hollow facial appearance that develops when tirzepatide therapy causes rapid facial fat loss. This phenomenon affects approximately 15-25% of women over 40 using weight loss medications and results from the body losing subcutaneous fat from the cheeks, temples, and under-eye areas faster than the skin can adapt. According to the [...]
Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery
Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and managing blood sugar levels. While taking Mounjaro, many patients report feeling tired-particularly during the initial [...]
Zepbound vs Wegovy: 20% vs 14% Weight Loss – Head-to-Head Trial
Zepbound beats Wegovy with 20.2% vs 13.7% body weight loss in the first-ever head-to-head trial (SURMOUNT-5), published in the New England Journal of Medicine. The key difference: Zepbound is a dual GLP-1 and GIP receptor agonist, while Wegovy targets only GLP-1. Both are FDA-approved injectable weight loss medications that require weekly injections alongside healthy eating [...]
How Much Weight Can You Lose on Wegovy? 15-17% Average + Timeline Chart
The average weight loss on Wegovy is 15% of body weight (approximately 35 pounds) after 68 weeks of treatment with the 2.4mg maintenance dose, according to clinical trial data published in the New England Journal of Medicine. This once-weekly injection, containing the active ingredient semaglutide, works by mimicking a natural hormone called GLP-1 that signals [...]
Wegovy for PCOS: 15% Weight Loss + Insulin Sensitivity Benefits
Wegovy for PCOS is gaining attention as a potential treatment option for women struggling with polycystic ovary syndrome and weight-related symptoms. Between 38% to 88% of women with PCOS are overweight or obese, making weight loss a primary treatment goal. Research shows that losing even 5-10% of body weight can improve many aspects of PCOS, [...]
Wegovy vs Mounjaro: Mounjaro (20%) Weight Loss vs Wegovy (14%) Complete Comparison
In the groundbreaking SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine, Mounjaro achieved 20.2% average weight loss compared to Wegovy's 13.7% over 72 weeks. The key difference lies in their mechanisms: Wegovy (semaglutide) is a GLP 1 receptor agonist that mimics a naturally occurring hormone to reduce appetite and control blood sugar. [...]
How to Use Wegovy Pen: Step-by-Step Instructions & Troubleshooting
The Wegovy pen is designed to be simple and user friendly for self administered injections. As a once weekly injection for weight management, Wegovy (semaglutide) comes in a pre filled, single dose pen that requires no manual dose selection. Each pen contains one exact preset dose making it nearly impossible to administer the wrong amount [...]
How Much Does Wegovy Cost 2026: Pill & Injection Complete Insurance & Savings Guide
Wegovy (semaglutide) is approved GLP-1 receptor agonist prescribed for chronic weight management alongside a reduced-calorie diet and increased physical activity. As of January 2026, Wegovy is available as both a weekly injection and a new daily pill, making it the first oral GLP-1 medication approved for weight loss in adults. The cost of Wegovy varies [...]
